ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,616Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 6645

$1.85M Total Retail Price of All Prescriptions

Rank: 98 out of 6645

1,427 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,427 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

30% of this provider’s 1,427 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 23,972 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 2,312 1,298 S3 1 5
SIMVASTATIN 1,392 1,048 2 1
LISINOPRIL 1,086 872 3 3
OMEPRAZOLE 1,011 717 4 6
LEVOTHYROXINE SODIUM 793 653 5 4
GABAPENTIN 739 449 6 18
METFORMIN HCL 694 505 7 7
TRAZODONE HCL 638 430 8 60
METOPROLOL TARTRATE 636 553 9 13
FUROSEMIDE 613 467 10 11
ATENOLOL 544 449 11 8
METOPROLOL SUCCINATE 540 414 12 24
BACLOFEN 536 307 13 100
AMLODIPINE BESYLATE 493 394 14 2
LOSARTAN POTASSIUM 469 361 15 12
TRAMADOL HCL 464 302 16 30
FLUOXETINE HCL 443 274 17 63
WARFARIN SODIUM 439 400 18 16
PREDNISONE 413 313 19 57
DIGOXIN 363 331 20 59
MIRTAZAPINE 362 314 21 70
CLONIDINE HCL 339 203 22 56
CARISOPRODOL 333 81 R 23 94
FLUTICASONE PROPIONATE 331 225 24 26
CARVEDILOL 325 259 25 25
LOVASTATIN 321 301 26 15
ADVAIR DISKUS 308 165 27 45
LANTUS 299 179 28 50
ZOLPIDEM TARTRATE 287 145 29 17
TAMSULOSIN HCL 286 253 30 22
POTASSIUM CHLORIDE 279 223 31 28
ATORVASTATIN CALCIUM 277 186 32 10
DONEPEZIL HCL 276 261 33 27
HYDROCHLOROTHIAZIDE 270 190 34 9
CIPROFLOXACIN HCL 265 195 35 67
ALENDRONATE SODIUM 263 247 36 14
MISOPROSTOL 259 160 37 377
RISPERIDONE 254 116 38 93
IBUPROFEN 248 113 39 42
SERTRALINE HCL 247 126 40 43
SPIRIVA 240 191 41 65
SYMBICORT 237 153 42 153
PANTOPRAZOLE SODIUM 232 168 43 29
MELOXICAM 221 132 44 46
FAMOTIDINE 218 178 45 33
OXYBUTYNIN CHLORIDE 209 162 46 129
CITALOPRAM HBR 193 120 47 35
PROPRANOLOL HCL 185 111 48 151
DIVALPROEX SODIUM 179 82 49 113
AMITRIPTYLINE HCL 176 112 R 50 117
PROAIR HFA 171 82 51 32
CLOPIDOGREL 168 147 52 36
TRIAMCINOLONE ACETONIDE 165 118 53 55
GLIMEPIRIDE 164 119 54 47
LEVETIRACETAM 164 115 54 119
PRAVASTATIN SODIUM 164 120 54 20
QUETIAPINE FUMARATE 161 95 57 101
DOXAZOSIN MESYLATE 154 118 58 81
NEXIUM 150 105 59 40
BUPROPION XL 147 41 60 225
VENTOLIN HFA 145 61 61 146
PHENYTOIN SODIUM EXTENDED 144 62 62 172
FINASTERIDE 141 132 63 73
PAROXETINE HCL 136 81 64 72
ROPINIROLE HCL 136 107 64 166
INSULIN SYRINGE 132 58 66 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 131 92 67 134
AMOXICILLIN 131 80 67 107
CYMBALTA 126 47 69 78
JANUVIA 126 66 69 38
MECLIZINE HCL 125 95 71 122
BENAZEPRIL HCL 121 86 72 21
CLINDAMYCIN HCL 119 80 73 477
VENLAFAXINE HCL ER 117 92 74 175
PLAVIX 117 104 74 49
ISOSORBIDE MONONITRATE ER 114 92 76 66
GLIPIZIDE 112 97 77 23
NAMENDA 111 108 78 41
ENALAPRIL MALEATE 109 90 79 75
ACTOS 109 79 79 71
CARBAMAZEPINE 107 30 81 224
MORPHINE SULFATE ER 107 71 S2 81 124
TIZANIDINE HCL 104 55 83 290
OXYBUTYNIN CHLORIDE ER 104 99 83 179
ALLOPURINOL 103 81 85 31
LEVEMIR 101 43 86 272
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 54 86 37
KLOR-CON 10 95 86 88 145
LIDODERM 95 76 88 53
LYRICA 95 57 88 127
IPRATROPIUM-ALBUTEROL 95 85 88 201
DIOVAN 94 76 92 19
NYSTATIN 93 48 93 234
ACETAMINOPHEN-CODEINE 92 50 S3 94 80
LAMOTRIGINE 92 30 94 284
GLYBURIDE 92 83 R 94 58
TOPIRAMATE 87 25 97 255
OLANZAPINE 84 19 98 140
LITHIUM CARBONATE 81 0 99 422
SINGULAIR 80 65 100 76
ABILIFY 74 13 101 204
KLOR-CON M10 73 69 102 276
PROMETHAZINE HCL 72 17 R 103 219
CARBIDOPA-LEVODOPA 72 68 103 116
NITROSTAT 71 60 105 193
CHOLESTYRAMINE 70 61 106 506
BUSPIRONE HCL 69 45 107 207
PIOGLITAZONE HCL 68 56 R 108 184
LORAZEPAM 66 62 109 189
HUMULIN R 65 59 110 209
RANITIDINE HCL 64 50 111 51
FLUOCINONIDE 63 48 112 130
COMBIVENT 63 43 112 174
DILTIAZEM 24HR CD 59 48 114 176
METRONIDAZOLE 58 42 115 329
QVAR 58 43 115 103
TRIAMTERENE-HYDROCHLOROTHIAZID 56 46 117 143
NIFEDIPINE ER 56 48 117 82
ALPRAZOLAM 56 56 117 195
CLONIDINE 56 40 117 308
SUMATRIPTAN SUCCINATE 55 13 121 306
ESTRADIOL 54 43 R 122 165
KLOR-CON 8 54 49 122 123
MONTELUKAST SODIUM 53 41 124 128
SEROQUEL 53 33 124 208
CRESTOR 53 33 124 34
NOVOLIN R 53 41 124 142
BYSTOLIC 53 48 124 110
ISOSORBIDE DINITRATE 52 29 129 200
NABUMETONE 52 37 129 190
CYCLOBENZAPRINE HCL 52 12 R 129 157
OXYCODONE HCL-ACETAMINOPHEN 51 35 S2 132 213
AMIODARONE HCL 51 42 132 160
LEVOXYL 50 43 134 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.